New hope for Tough-to-Treat colorectal cancer?
Disease control
Recruiting now
This study tests a new drug combination for people with advanced colorectal cancer that has not responded to standard treatments. The trial adds an experimental drug called isunakinra to an existing immunotherapy (pembrolizumab) to see if it can help control the cancer. About 20 …
Phase: PHASE2 • Sponsor: Buzzard Pharmaceuticals • Aim: Disease control
Last updated May 06, 2026 09:15 UTC